Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.78
-0.62 (-7.38%)
At close: Aug 28, 2026, 4:00 PM EDT
7.85
+0.07 (0.90%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $214.74 million as of August 28, 2026. Its market cap has increased by 263.64% in one year.
Market Cap
214.74M
Enterprise Value
155.29M
1-Year Change
263.64%
Ranking
Category
Stock Price
$7.78
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $214.74M, a decrease of -74.89%. That is a compound annual growth rate of -16.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 214.74M | 114.44% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 225.28M |
| Keros Therapeutics | 218.69M |
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |
| NovaBridge Biosciences | 213.44M |
| PepGen | 213.32M |
| Acumen Pharmaceuticals | 211.17M |
| Corbus Pharmaceuticals Holdings | 211.01M |